Filing Details
- Accession Number:
- 0001213900-19-020722
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-21 16:23:29
- Reporting Period:
- 2019-10-21
- Accepted Time:
- 2019-10-21 16:23:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1658369 | Maged Shenouda | C/O Relmada Therapeutics, Inc. 880 Third Avenue, 12Th Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-10-21 | 978 | $23.00 | 2,228 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |